These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 26177578)

  • 41. Cytokines in the central nervous system: targets for therapeutic intervention.
    Safieh-Garabedian B; Haddad JJ; Saadé NE
    Curr Drug Targets CNS Neurol Disord; 2004 Aug; 3(4):271-80. PubMed ID: 15379603
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [The role of inflammatory reaction in Alzheimer's disease and neurodegenerative processes].
    Członkowska A; Kurkowska-Jastrzebska I
    Neurol Neurochir Pol; 2002; 36(1):15-23. PubMed ID: 12053606
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Connection between inflammatory processes and transmittor function-Modulatory effects of interleukin-1.
    Spulber S; Schultzberg M
    Prog Neurobiol; 2010 Feb; 90(2):256-62. PubMed ID: 19853010
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The type 2 diabetes drug liraglutide reduces chronic inflammation induced by irradiation in the mouse brain.
    Parthsarathy V; Hölscher C
    Eur J Pharmacol; 2013 Jan; 700(1-3):42-50. PubMed ID: 23276669
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuroinflammation in Parkinson's disease: role in neurodegeneration and tissue repair.
    Vivekanantham S; Shah S; Dewji R; Dewji A; Khatri C; Ologunde R
    Int J Neurosci; 2015; 125(10):717-25. PubMed ID: 25364880
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of Alzheimer's and Parkinson's diseases.
    Kawamata J; Shimohama S
    J Alzheimers Dis; 2011; 24 Suppl 2():95-109. PubMed ID: 21403387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Inflammation and Alzheimer's disease].
    de Toledo M
    Rev Neurol; 2006 Apr 1-15; 42(7):433-8. PubMed ID: 16602061
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inflammatory mechanisms in Alzheimer's disease: implications for therapy.
    Aisen PS; Davis KL
    Am J Psychiatry; 1994 Aug; 151(8):1105-13. PubMed ID: 7518651
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glatiramer acetate could be a potential therapeutic agent for Parkinson's disease through its neuroprotective and anti-inflammatory effects.
    Tsai SJ
    Med Hypotheses; 2007; 69(6):1219-21. PubMed ID: 17548170
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Investigations with cultured human microglia on pathogenic mechanisms of Alzheimer's disease and other neurodegenerative diseases.
    Walker DG; Lue LF
    J Neurosci Res; 2005 Aug; 81(3):412-25. PubMed ID: 15957156
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inhibition of microglial inflammation by the MLK inhibitor CEP-1347.
    Lund S; Porzgen P; Mortensen AL; Hasseldam H; Bozyczko-Coyne D; Morath S; Hartung T; Bianchi M; Ghezzi P; Bsibsi M; Dijkstra S; Leist M
    J Neurochem; 2005 Mar; 92(6):1439-51. PubMed ID: 15748162
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Necrotic neurons enhance microglial neurotoxicity through induction of glutaminase by a MyD88-dependent pathway.
    Pais TF; Figueiredo C; Peixoto R; Braz MH; Chatterjee S
    J Neuroinflammation; 2008 Oct; 5():43. PubMed ID: 18844999
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The Contribution of Formyl Peptide Receptor Dysfunction to the Course of Neuroinflammation: A Potential Role in the Brain Pathology.
    Trojan E; Bryniarska N; Leśkiewicz M; Regulska M; Chamera K; Szuster-Głuszczak M; Leopoldo M; Lacivita E; Basta-Kaim A
    Curr Neuropharmacol; 2020; 18(3):229-249. PubMed ID: 31629396
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Role of Immune and Inflammatory Mechanisms in Stroke: A Review of Current Advances.
    Zhao H; Li Y; Zhang Y; He WY; Jin WN
    Neuroimmunomodulation; 2022; 29(4):255-268. PubMed ID: 35640538
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The importance of inflammatory mechanisms in Alzheimer disease.
    McGeer EG; McGeer PL
    Exp Gerontol; 1998 Aug; 33(5):371-8. PubMed ID: 9762518
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Current and future therapeutic strategies to target inflammation in stroke.
    Zhang W; Stanimirovic D
    Curr Drug Targets Inflamm Allergy; 2002 Jun; 1(2):151-66. PubMed ID: 14561197
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Towards a unifying hypothesis of neurodegenerative diseases and a concomitant rational strategy for their prophylaxis and therapy.
    Oken RJ
    Med Hypotheses; 1995 Oct; 45(4):341-2. PubMed ID: 8577296
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseases.
    McGeer PL; McGeer EG
    Brain Res Brain Res Rev; 1995 Sep; 21(2):195-218. PubMed ID: 8866675
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inflammation as common link to progressive neurological diseases.
    Dias-Carvalho A; Sá SI; Carvalho F; Fernandes E; Costa VM
    Arch Toxicol; 2024 Jan; 98(1):95-119. PubMed ID: 37964100
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Old and new inflammation and infection hypotheses of Alzheimer's disease: focus on Microglia-aging for chronic neuroinflammation].
    Wu Z; Nakanishi H
    Nihon Yakurigaku Zasshi; 2017; 150(3):141-147. PubMed ID: 28890476
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.